Edit

Tag:

metabolomics

Showing results out of

Year
7 February 2023 BII and EMBL logos are on a white band set against a wavy green background

Promoting European innovation in the life sciences

One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…

CONNECTIONSLAB MATTERS

2023

connectionslab-matters

8 September 2021 Illustration of two halves of a pill, which releases chemical molecules that are taken up by gut bacteria in the vicinity.

Common medications accumulate in gut bacteria

A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.

SCIENCE & TECHNOLOGY

2021

sciencescience-technology

27 April 2021 Microscope image of liver cells, highlighted in various colours.

Painting liver cells

A page from a biologist’s colouring book? EMBL’s new interior wall design? Not quite – a bunch of liver cells, grown in the lab so that scientists can learn about fatty liver disease, or steatosis.

SCIENCE & TECHNOLOGY

2021

picture-of-the-weekscience-technology

No results found

News archive

E-newsletter archive

EMBLetc archive

News archive

For press

Contact the Press Office
Edit